Alexandra Kropotova - 18 Dec 2024 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Signature
/s/ Alexandra Kropotova
Issuer symbol
SABS
Transactions as of
18 Dec 2024
Net transactions value
$0
Form type
4
Filing time
31 Dec 2024, 17:49:34 UTC
Previous filing
25 Nov 2024
Next filing
01 Apr 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SABS Common Stock Tax liability -9,072 -16% 48,428 18 Dec 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer's common stock ("Common Stock") withheld to satisfy tax withholding requirements on the vesting of the Issuer's restricted stock units ("RSUs").
F2 Includes 21,712 shares of Common Stock and 26,716 shares of Common Stock which remain subject to vesting of RSUs granted under the Issuer's 2021 Equity Incentive Plan, as amended.
F3 Each RSU represents a contingent right to receive one share of Common Stock.